Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibitors: resolving diagnostic and therapeutic dilemmas.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 May 2002

Dimichele D

Abstract excerpt

The good quality of life now anticipated by individuals with haemophilia A and B can be drastically altered by the unpredictable development of an inhibitor, a polyclonal high-affinity IgG antibody directed against factor VIII or IX. This paper discusses our current state of knowledge about inhibitors within the context of: (1) the extent and nature of the problem, including its incidence and prevalence,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor IX
Share to Factor VIII
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemophilia A

Share to Hemophilia B

Share to Isoantibodies

Share to Risk Factors

Source

Identifiers

PMID: 12010424
DOI: 10.1046/j.1365-2516.2002.00626.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibitors: resolving diagnostic and therapeutic dilemmas.PMID 12010424Read ↗

Inhibitors in haemophilia: pathophysiology.Semantic proximity Read ↗

Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.Semantic proximity Read ↗

Inhibitors in mild/moderate haemophilia A: an update.Semantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

Factor VIII inhibitors.Semantic proximity Read ↗

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors.Semantic proximity Read ↗

Assessing risk factors: prevention of inhibitors in haemophilia.Semantic proximity Read ↗

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read ↗

Characteristics of inhibitors in mild/moderate haemophilia A.Semantic proximity Read ↗

Key insights to understand the immunogenicity of FVIII products.Semantic proximity Read ↗

Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.Semantic proximity Read ↗

Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.